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ABSTRACT
We had described that epidermal growth factor (EGF) interfered
with the lipolytic effect of catecholamines in isolated adipocytes. Since
catecholamines stimulate the release of EGF from submandibular
salivary glands to blood plasma in male mice, we studied whether
EGF affected also the lipolytic response to adrenaline in whole ani-
mals. We studied the effect of adrenaline in sialoadenectomized and
sham-operated mice receiving or not a high dose of EGF following
adrenaline injection. There was no difference in plasma EGF con-
centration between sham-operated and sialoadenectomized animals
receiving saline. After adrenaline administration plasma EGF in-
creased by 20-fold in sham-operated but did not increase in siaload-
enectomized mice. Indeed, the increase was much higher (more than
100-fold) in mice receiving exogenous EGF. The effect of adrenaline
on plasma concentration of both glycerol and nonesterified fatty acids
was higher as lower was plasma EGF concentration. Isolated adipo-
cytes obtained from sham-operated or sialoadenectomized mice had
identical lipolytic response to adrenaline. The lipolytic response of
adipocytes to isoproterenol was decreased by addition of EGF. To
study whether the interference with the in vivo lipolytic effect of
adrenaline had further metabolic consequences, we measured plasma
b-hydroxybutyrate concentration in plasma. There was no difference
in the response to adrenaline between sham-operated and siaload-
enectomized mice in spite of the difference in plasma nonsterified
fatty acid concentration. Studies in isolated hepatocytes indicated
that ketogenesis run at near maximal rate in this range of substrate
concentration. These results suggest that EGF in the physiological
range decreases the lipolytic effect of adrenaline but does not com-
promise further metabolic events like the enhancement of ketogen-
esis. (Endocrinology 141: 876–882, 2000)
EPIDERMAL GROWTH FACTOR (EGF) is a mitogen formany cells in culture, adipocyte precursors among
them. In these cells, EGF stimulates proliferation and blocks
differentiation (1, 2). The physiological relevance of this ef-
fect of EGF in adipose tissue development was established by
Serrero and Mills (3). They found that daily sc administration
of EGF to newborn rats for 10 days resulted in a substantial
decrease of fat pad weight, but also in an increase of adipo-
cyte precursor cell number.
Besides of the mitogenic effect, EGF is able to affect the
function of nonproliferating cells too. A remarkable example
is mature adipocytes. In these cells EGF has opposed effects
to those in their precursors: it stimulates adipogenesis (4). In
keeping with this function, it has been reported that EGF
stimulates metabolic pathways leading to lipid accumulation
in differentiated adipocytes. Thus, EGF stimulates acetyl-
CoA carboxylase activity (5) and increases conversion of
14C-glucose into fatty acids (6). EGF stimulates also the re-
lease of lipoprotein lipase from adipocytes (6) and inhibits
both glucagon- and isoproterenol-stimulated lipolysis (7).
Metabolic studies in mature adipocytes generate questions
at both the molecular and physiological levels. Regarding
molecular mechanisms involved in the effect of EGF,
progress has been slow because the magnitude of effects in
mature adipocytes is small. Although effects of EGF resemble
those of insulin, it becomes clear that the mechanisms in-
volved are different. This was shown for the effect on lipol-
ysis. Both EGF and insulin modulate the cAMP signal
generated by lipolytic hormones like glucagon or cat-
echolamines (6). While the target of insulin action is the cyclic
GMP-inhibited phosphodiesterase (cGI-PDE) (8), through a
phosphatidylinositol 3-kinase-dependent mechanism (9), the
target of EGF action is the interaction between Gs and Gi
proteins in the control of adenylate cyclase (7). This effect
does not involve wortmannin-sensitive substrates (6), which
is in keeping with the recent observation that EGF does not
stimulate phosphatidylinositol 3-kinase in 3T3-L1 adipo-
cytes (10).
Concerning the physiological relevance of the effects ob-
served in differentiated adipocytes, different approaches
raised opposite conclusions. Thus, surgical removal of the
major production site of EGF in mice, submandibular sali-
vary glands, impaired adipose tissue weight gain induced by
ovariectomy (11), or by aging (12) in mice. On the contrary,
systemic administration of EGF reduced fat mass in rats (13).
Because all these studies involved long-term experiments,
some indirect effects could explain the differences in these
results. Adipose tissue mass depends on the balance between
adipogenic and lipolytic hormones. In mice, among other
effects, catecholamines stimulate the secretion of EGF from
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submandibular salivary glands to saliva and also to blood
plasma (14). We took advantage of this model to determine
not only if exogenous EGF could interfere with the lipolytic
effect of adrenaline, as we had found in isolated cells (6, 7),
but also whether endogenous EGF secreted upon adrenaline
stimulation could do so.
Materials and Methods
Animals
Adult Swiss-CD1 mice were obtained from Interfauna (Barcelona,
Spain). All animals were male, fed ad libitum, and maintained under a
constant 12-h light, 12-h dark cycle (lights on at 0800 h) and controlled
conditions of humidity (45–55%) and temperature (22 6 1 C). All ex-
perimental procedures were approved by the Committee on Animal
Care of the University of Barcelona.
Sialoadenectomy
In diethyl ether-anaesthetized mice, a small incision was made to
expose the submandibular salivary glands, which were then ligated and
excised. In control (sham-operated) animals, the glands were exposed,
and a ligature was passed, but not tied. The wound was stitched and
disinfected. Sham-operated and sialoadenectomized animals were kept
fasted for the next 24 h. We have observed that postsurgery fasting
allows similar recovery and growth pattern of both groups. Two weeks
later, mice had recovered completely and were used for experiments.
Experiments in whole animals
Mice were anaesthetized (sodium pentobarbital 60 mg kg21) before
receiving an iv (0.37 mg kg21) plus an ip (1.25 mg kg21) injection of
adrenaline (Sigma, St. Louis, MO). In some experiments, animals were
immediately injected with EGF (Roche Molecular Biochemicals, Mann-
heim, Germany) (0.25 mg kg21, iv). Control animals received identical
volumes of saline. At indicated time, blood was collected into heparin-
ized syringes from the inferior vena cava. Blood plasma was obtained
by centrifugation. A sample was deproteinized and neutralized as in-
dicated in (15) and used for glucose (16), glycerol (17), nonesterified fatty
acid (NEFA) (NEFA C ACS-ACOD method, Wako Pure Chemical Co.,
Neuss, Germany), and b-hydroxybutyrate (18) quantification. Another
sample was processed as indicated in (19) for EGF quantification. Im-
mediately after bleeding, submandibular salivary glands were excised
and homogenized in 10 ml PBS. After centrifugation (100,000 3 g for 60
min at 4 C) the supernatant was stored at 240 C for EGF quantification
(19).
To study the effect of immobilization stress, mice (under a very light
ether anesthesia) were fixed with adhesive tape to a table in a supine
position. In less than 1 min, the effect of ether completely disappeared
and acute stress symptoms were observed. After 20 min, animals were
killed and processed as indicated above. Liver glycogen and plasma
glucose were determined as indicated elsewhere (15).
Experiments in isolated adipocytes
Adipocytes were isolated from the epididymis by the method of
Rodbell (20) with minor modifications. One gram of adipose tissue
(combining the mass obtained from several mice) was digested in plastic
vials with 3 ml of Krebs-Henseleit buffer containing 1 mm CaCl2, 5 mm
glucose, 3% BSA (buffer A), and 0.5 mg of collagenase/ml. Digestion was
carried out at 37 C for 40 min and under constant shaking (120 cycles/
min). Dispersed cells were filtered through a double-layered nylon mesh
and washed four times with buffer B (as buffer A but with 0.5 mm CaCl2).
After counting in a Neubauer hemocytometer, the cells were suspended
in buffer B. Lipolysis was determined in isolated adipocytes as the
amount of glycerol produced by the cells during an incubation period.
After isolation, adipocytes (1.75 3 105 cells/ml) were placed in plastic
vials (containing the indicated additions) at 37 C, under constant shaking
and oxygenation with O2/CO2 (95%:5%). Both at zero time and 30 min
afterwards, a sample (1 ml) was withdrawn and immediately placed into
enough perchloric acid to give a final concentration of 3%. Neutralized
supernatants were used to determine glycerol (17). In every experiment,
incubations were performed in triplicate. Preliminary experiments
showed that the rate of lipolysis was proportional to cell density between
0.5 3 105 and 4 3 105 adipocytes/ml, and linear with incubation time
for at least 60 min, even in the presence of lipolytic agents.
Experiments in isolated hepatocytes
Hepatocytes were isolated from the liver of adult male mice as pre-
viously described (15). Initial cell viability measured by the trypan blue
exclusion test was over 90% and decreased less than 10% during the
incubations (up to 60 min). Isolated hepatocytes were then incubated
(2 3 106 cells/ml, final volume 2 ml) in a 20 mm-HEPES (pH 7.4)-
containing buffer supplemented with 1%-albumin (21), but without
FIG. 1. Dose-dependent effect of adrenaline on lipolysis and EGF in
plasma. Anaesthetized mice were injected with 0.37 mg kg21 of adren-
aline (iv) and the indicated dose ip. Controls received iv and ip vol-
umes of saline. After 10-min samples were obtained to measure
plasma glycerol, and b-hydroxybutyrate, and plasma and subman-
dibular gland (SMG) EGF concentration. Results are the mean 6 SE
of five animals per group. Statistical comparisons vs. control value
were made by Student’s t test. * P , 0.05; ** P , 0.01; *** P , 0.001.
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glucose. Oleate-albumin complex was prepared as in (22) immediately
before use. At the end of the incubation a sample of the suspension was
placed into enough ice-cold HClO4 to give a final concentration of 3%.
After neutralization, b-hydroxybutyrate and acetoacetate concentra-
tions were determined (18).
Results
In a preliminary experiment we studied the effect of dif-
ferent ip doses of adrenaline primed by an iv dose of 0.37 mg
kg21 (Fig. 1). All three doses raised plasma glycerol concen-
tration up to similar level. b-Hidroxybutyrate, a product of
fatty acid metabolization in liver, showed a similar pattern.
Plasma EGF concentration increased only after the middle
(0.75 mg kg21) and the highest (1.5 mg kg21) doses. The
increase of glycerol concentration was significant since the
second min after adrenaline injection (1.25 mg kg21), reached
maximal value at 10 min and decreased thereafter (Fig. 2).
b-Hidroxybutyrate concentration reached also maximal
value at 10 min, but remained higher than control values for
at least 60 min. EGF content in submandibular glands de-
creased to a half in about 10 min after adrenaline injection
and remained low for at least 60 min. EGF in plasma pro-
gressively increased during the first 10 min, and decreased
thereafter. The kinetics of EGF secretion upon adrenaline
injection was similar to that obtained after phenylephrine
injection (19).
To determine whether the effects of the adrenaline dose
chosen for next experiments (priming dose of 0.37 mg kg21
iv, followed by 1.25 mg kg21 ip) were similar to those of a
physiological stress situation, we compared the effect of
adrenaline in anaesthetized mice to that of immobilization of
conscious mice. In both, adrenaline injected and immobilized
mice liver glycogen was decreased and plasma glucose con-
centration was increased (Table 1). The raise of plasma glu-
cose concentration (2.0-fold) and the decrease of liver gly-
cogen content (40%) was higher in adrenaline injected than
in immobilized mice (1.7-fold increase and 28% decrease for
plasma glucose and liver glycogen, respectively). In both
models, submandibular gland EGF content decreased and
plasma EGF concentration increased in a similar extent.
Because we wanted to study the effect of a stress hormone
in surgically manipulated animals, we had to allow them to
recover from surgical stress before the experiment. We let the
animals to stand for 2 weeks before adrenaline administra-
tion (time required for complete wound healing); therefore,
we had to compare first both groups: sham-operated and
sialoadenectomized mice. Results are shown in Table 2.
FIG. 2. Time-course of the effect of adrenaline on lipolysis and EGF
in plasma. Anaesthetized mice were injected with adrenaline (0.37 mg
kg21 iv and 1.25 mg kg21 ip). Controls received iv and ip volumes of
saline. At indicated times, animals were killed and samples were
obtained to measure plasma glycerol, and b-hydroxybutyrate, and
plasma and submandibular gland (SMG) EGF concentration. Results
are the mean 6 SE of five animals per group. Statistical significance
of differences vs. corresponding control value are indicated by: * P ,
0.05; ** P , 0.01; *** P , 0.001.
TABLE 1. Effect of adrenaline administration to anaesthetized mice or immobilization of conscious mice on glycogenolysis and plasma
EGF
Time (min) . . .
IMMO ADR
0 20 0 20
Liver glycogen (mg/g) 45.3 6 1.9 32.7 6 2.3a 45.4 6 5.0 27.3 6 4.0b
Plasma glucose (mM) 11.9 6 0.2 18.2 6 0.7a 10.6 6 0.5 24.2 6 0.6a
EGF in SMG (nmol/g) 142 6 20 68 6 11b 190 6 25 90 6 10b
EGF in plasmad (nM) 0.19 6 0.03 1.24 6 0.74c 0.13 6 0.05 1.14 6 0.54c
Mice were either anaesthetized and injected with 0.37 mg kg21 (iv) and 1.25 mg kg21 (ip) of adrenaline (ADR), or subjected to immobilization
stress (IMMO). At the indicated time (0 or 20 min) animals were killed to obtain samples. Results are the mean 6 SE of 10–15 animals per
group. Statistical significance of differences vs. corresponding control value are indicated by: a P , 0.001; b P , 0.01; c P , 0.05. SMG,
Submandibular glands. (d Since there were no homogeneity of variances, statistical analysis was performed on logarithmic transformation of
values).
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There were no differences in the appearance of sialoadenec-
tomized and sham-operated mice. Both groups had similar
body, epididymal adipose tissue, and liver weight. Both had
similar daily food intake. Sialoadenectomized mice had
somehow lower water intake, but the differences were not
significant. They also had similar blood plasma glucose, glyc-
erol, and nonesterified fatty acids concentration. Finally, al-
though sialoadenectomized mice had no submandibular
glands, plasma EGF concentration was not decreased.
Next we studied the effect of adrenaline injection, with or
without an additional supplementation of EGF, in sham-
operated and sialoadenectomized mice. The results are
shown in Fig. 3. Plasma EGF concentration did not increase
in sialoadenectomized mice upon adrenaline administration,
but increased near 20-fold in sham-operated animals. As
expected, plasma EGF concentration at the time the mice
were killed was even higher in both groups of mice receiving
an exogenous bolus of EGF. Adrenaline injection to sham-
operated mice decreased EGF content in submandibular sal-
ivary glands from 207 6 12 nmol/g (saline-injected mice
value) to 112 6 9 nmol/g in adrenaline injected mice, and to
93 6 12 nmol/g in adrenaline 1 EGF injected mice (differ-
ences are significantly different to control value, P , 0.001).
Adrenaline administration increased glycerol and NEFA
concentration in plasma of sham-operated animals, the in-
crease was significantly higher in sialoadenectomized mice.
Exogenous EGF reduced the effect of adrenaline on glycerol
concentration and almost abolished that on NEFA concen-
tration in both groups of animals. To determine whether the
alteration in the lipolytic response to adrenaline had conse-
quences on ketogenesis we determined b-hydroxybutyrate
concentration in plasma. Adrenaline administration in-
creased b-hydroxybutyrate concentration in sham-operated
and sialoadenectomized mice up to similar values. Exoge-
nous supplementation of EGF reduced the response to adren-
aline in both groups of animals.
In Fig. 4 we show the relationship between plasma EGF
concentration and the effect of adrenaline (adrenaline minus
saline values) on plasma glycerol and NEFA concentration.
There was a significant negative correlation for both glycerol
and NEFA. There was, however, no significant correlation
between the effect of adrenaline on plasma b-hydroxybu-
tyrate concentration and plasma EGF (not shown).
To rule out that the enhanced lipolytic response to adren-
aline in sialoadenectomized mice was due to differences in
the sensitivity of adipose tissue cells to catecholamines, we
TABLE 2. Characteristics of sham-operated and
sialoadenectomized mice
Sham-operated Sialoadenectomized
Whole animal parameters
Body weight (g) 47.3 6 0.7 47.2 6 0.9
Food intake (g/day) 6.7 6 0.2 7.0 6 0.5
Water intake (ml/day) 8.9 6 1.0 6.7 6 0.8
Tissue weight (g)
EAT 0.48 6 0.07 0.51 6 0.02
Liver 2.25 6 0.11 2.18 6 0.04
Plasma biochemistry
Glucose (mM) 9.8 6 0.3 9.8 6 0.4
Glycerol (mM) 0.12 6 0.01 0.12 6 0.01
NEFA (mM) 0.53 6 0.03 0.49 6 0.04
b-hydroxybutyrate (mM) 0.05 6 0.01 0.06 6 0.01
EGF (nM) 0.11 6 0.02 0.15 6 0.02
Animals were operated under ether anesthesia. They were kept
fasted for the next 24 h and then allowed to have free access to food.
This table compares both groups of animals 2 weeks after surgery.
Results are mean 6 SE of six animals. Food and water intake were
measured through the recovery period, and the results shown corre-
sponds to the whole period mean value. EAT, Epididymal adipose
tissue (both depots of each animal). Statistical comparisons were
made by Student’s t test. Differences were not significant.
FIG. 3. Effect of EGF on the lipolytic effect of adrenaline. Two weeks
after surgery sham-operated (white bars) and sialoadenectomized
(dotted bars) mice were anesthetized and injected with adrenaline
(0.37 mg kg21 iv 1 1.25 mg kg21 ip) (ADR) or saline. Some mice
received EGF (0.25 mg kg21 iv) together with the adrenaline injection
(ADR1EGF). Ten min afterward blood was obtained for assays in
plasma. Results are mean 6 SE of 12 to 20 animals per group. Sta-
tistical significance of the differences vs. corresponding saline (*) or
sham-operated () value are indicated by: *,  P , 0.05; **,  P ,
0.01; *** P , 0.001.
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studied the effect of adrenaline in isolated adipocytes from
sham-operated and sialoadenectomized animals. The results
are shown in Fig. 5A. From the four experiments done, we
obtained a basal (nonstimulated) lipolysis that was similar in
cells from sham-operated and sialoadenectomized mice
(0.13 6 0.03 and 0.12 6 0.01 mmol glycerol released/30 min 3
106 adipocytes, respectively; differences were not signifi-
cant). There were no differences either in ED50 value (0.22 6
0.01 and 0.21 6 0.01 mm for sham-operated and sialoadenec-
tomized mice, respectively), or in maximally stimulated li-
polysis (2.22 6 0.25 and 2.06 6 0.08 mmol glycerol re-
leased/30 min 3 106 adipocytes for sham-operated and
sialoadenectomized mice, respectively).
Next, we tested the direct effect of EGF on lipolysis in
isolated mice adipocytes (Fig. 5B). We had previously ob-
served in rat cells (6, 7) that EGF interfered the lipolytic effect
of catecholamines. Our purpose was, therefore, to demon-
strate that it happens also in mouse cells. EGF did not affect
basal glycerol release. In the presence of the b-adrenergic
agonist isoproterenol, lipolysis increased to 0.55 6 0.01 mmol
glycerol/30 min 3 106 cells, but only to 0.34 6 0.02 mmol
glycerol/30 min 3 106 cells in cells incubated with isopro-
terenol and EGF. Very similar results were obtained if cells
were incubated in the presence of adrenaline instead of iso-
proterenol (data not shown).
Finally, to understand the results concerning plasma b-hy-
droxybutyrate concentration we studied the effect of EGF on
ketogenesis in isolated hepatocytes. Results are shown in Fig.
6. In the absence of EGF, increasing concentrations of oleate
resulted in an enhanced rate of ketogenesis with an estimated
maximal rate of 646 6 78 nmol KB/106 cells 3 60 min and
S0.5 (substrate concentration that allows a half-maximal rate
of ketogenesis) of 0.29 6 0.04 mm. EGF did not affect maximal
rate of ketogenesis (709 6 107 nmol KB/106 cells 3 60 min,
nonsignificant differences) but increased moderately S0.5
value (0.45 6 0.05 mm, P , 0.05).
Discussion
Adrenaline stimulates the secretion of EGF from subman-
dibular salivary glands to both saliva and plasma in mice (14,
19). We have found that EGF interferes with the lipolytic
response of isolated adipocytes to catecholamines (7). Our
purpose in this paper was to find out whether this happens
also in the whole animal. To this end we took advantage of
the male mice model in which sialoadenectomy abolishes the
increase in plasma EGF upon catecholamine administration.
FIG. 4. Relationship between plasma EGF concentration and the li-
polytic effect of adrenaline. Data in Fig. 3 was used to plot the rela-
tionship between mean plasma EGF and the effect of adrenaline on
glycerol or NEFA concentration. The effect of adrenaline was calcu-
lated as the difference between mean adrenaline (with or without
EGF injection) and its corresponding mean saline value.
FIG. 5. Lipolysis in isolated adipocytes. A, Adipocytes were isolated simultaneously from combined epididymal adipose tissue of four sham-
operated (F) or sialoadenectomized (E) mice in each experiment. After isolation, cells were incubated in triplicate with the indicated concen-
tration of adrenaline at 37 C. After 30 min of incubation, lipolysis was measured as the amount of glycerol released to the incubation medium.
This figure shows the results of a representative experiment (out of four identical experiments made with different cell preparations). Each
point corresponds to the mean value of the triplicate. B, Adipocytes were isolated from nonoperated mice and incubated in the absence of EGF
(white bars) or in the presence of 100 nM EGF (black bars), and with or without 10 nM isoproterenol (ISO). Results are the mean 6 SE of four
experiments. Statistical significance of the differences vs. corresponding basal (*) or no EGF () value are indicated by: **,  P , 0.01.
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We could therefore test whether endogenous EGF had any
effect on adipose tissue response to catecholamines.
Based on preliminary experiments, we chose a dosage
procedure that induced somehow stronger effect than im-
mobilization stress on liver glycogen and plasma glucose
concentration. It was described that plasma glucose concen-
tration is sensitive to stress intensity (23); it was thus a good
parameter to compare both models. In spite of this small
difference, the effect on EGF in submandibular glands and
plasma was identical.
Although sialoadenectomized mice had not submandib-
ular glands, plasma EGF concentration was not decreased.
This was observed by many investigators before (14, 19, 24,
25) and was attributed to the fact that EGF is synthesized in
other cell types, some of which can overexpress the gene as
a consequence of sialoadenectomy (26). What surgical re-
moval of submandibular glands does is to abolish the in-
crease of plasma EGF concentration upon adrenergic stim-
ulation (14, 19). This explains why both groups have similar
plasma EGF concentration when maintained in nonstressful
conditions.
Our in vivo experimental design allowed to study the effect
of both endogenous and exogenous EGF on the response of
adipose tissue to adrenaline. The results demonstrate that
EGF interferes with the lipolytic effect of adrenaline in the
whole animal system: as lower is plasma EGF concentration,
stronger is the effect of adrenaline on both glycerol and
NEFA concentrations. The difference in the lipolytic re-
sponse to adrenaline between sham-operated and sialo-
adenectomzed mice cannot be attributed to differences
in adipose tissue mass or to adipocyte sensitivity to cat-
echolamines. Rather, it may be the consequence of the in-
terference with stimulation of lipolysis in adipocytes. Indeed,
exogenous EGF decreased the effect of adrenaline, and the
differences between sham-operated and sialoadenectomized
mice disappeared. This is in keeping with the observation
that plasma EGF concentration was similar in both groups
animals.
Concerning the mechanisms involved in the effect of EGF
on catecholamine-stimulated lipolysis, we had observed that
it was the result of the interference with the cAMP signal
induced by catecholamines in these cells (7). It is known that
besides of the effect on cellular cAMP, the action on regional
blood flow contributes also to the in vivo lipolytic effect of
adrenaline (27). Whether the effect of EGF is attributable only
to the interference with the intracellular signal, or it involves
also an interference with the regional hemodynamic effect of
adrenaline, as it happens with some antilipolytic hormones
like vasopressin (28), will require further investigations. Al-
though it is known that EGF has hemodynamic effects in vivo
(29), and produces vasoconstriction in isolated aortic prep-
arations (30, 31), nothing is known about the interaction
between EGF and adrenaline on adipose tissue vasculature.
The liver is one of the main destinations of fatty acids
derived from adipose tissue. In this organ, fatty acids may be
incorporated into complex lipids (triglycerides and phos-
pholipids) and finally into secreted lipoproteins, but they are
also fuels that provide most of the energy required by the
cells. Ketogenesis is tightly coupled to b-oxidation, which in
turn depends on substrate availability. Our results illustrate
the close relationship between plasma fatty acid concentra-
tion and ketogenesis. We obtained an S0.5 for ketogenesis
from oleate of 0.29 mm, a value close to plasma NEFA con-
centration in control animals. This indicates that ketogen-
esis is indeed sensitive to variation of plasma NEFA
concentration.
Looking at the relationship between oleate concentration
and ketogenesis in hepatocytes, the decreased b-hydroxy-
butyrate concentration found in EGF(1adrenaline) injected
mice compared with values obtained in adrenaline injected
animals can be attributed in part to a decreased substrate
availability (in these animals plasma NEFA concentration
dropped from 0.7–1.0 mm to 0.5 mm). In addition to substrate
availability, mitochondrial fatty acid oxidation, and hence
ketogenesis, depends on the control of carnitine palmitoyl-
transferase I (32). This enzyme is directly regulated by ma-
lonyl-CoA (33), the product of the acetyl-CoA carboxylase
reaction. Both enzymes are thus, reciprocally regulated. EGF
activates acetyl-CoA carboxylase in adipocytes (5). In hepa-
tocytes, Holland and Hardie (34) found that EGF induced
phosphorylation of this enzyme, which was in keeping with
an enhanced lipogenesis. In keeping with these reported
effects of EGF, we observed that this peptide increased oleate
S0.5 required for half-maximal ketogenesis in hepatocytes.
Therefore, besides of the decreased substrate availability, the
reduced ketogenic sensitivity of the liver may explain the low
b-hydroxybutyrate concentration found in EGF injected
mice.
In a more physiological context, the raise of plasma EGF
concentration (the difference between sialoadenectomized
and sham-operated animals receiving adrenaline), although
decreased the lipolytic response to adrenaline, had no effect
on plasma b-hydroxybutyrate. This is understandable be-
cause plasma NEFA concentration decreased from 1.0 mm
(sialoadenectomized animals) to 0.7 mm (sham-operated an-
imals with higher EGF concentration in plasma), and we
FIG. 6. Effect of EGF on ketogenesis in isolated hepatocytes. Hepa-
tocytes were isolated from nonoperated mice. After isolation cells
were incubated with the indicated concentration of oleate either with-
out (E) or with (F) EGF (100 nM). After 60 min, incubation medium
was obtained to determine ketone bodies (KB). Each experimental
condition was made in triplicate. The results are the mean 6 SE of four
identical experiments made with different cell preparations.
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observed in isolated hepatocytes that within this range of
oleate concentrations ketogenesis is near saturation and thus,
unsensitive to such a small decrease in substrate availability.
Therefore, we may conclude that, under physiological con-
ditions, one of the metabolic consequences of adipose tissue
lipolysis (the increased ketogenesis in liver) is not compro-
mised by the effect of endogenously secreted EGF on lipol-
ysis. If the interference with the lipolytic action of adrenaline
has no further metabolic consequences, we could conclude
also that such an interference is meaningful only for adipose
tissue itself: EGF would reduce the intensity of one of the
major lipolytic stimulus affecting thus, the balance between
adipogenesis and lipolysis. This would favor triglyceride
accumulation, which is in keeping with other effects of EGF
described in adipocytes (4–6), and in whole animals (11, 12).
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